Patents by Inventor Sarah Stanley

Sarah Stanley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11485699
    Abstract: The invention provides (meth)acrylic oligomers prepared from C1-C20 alkyl and C5-C20 cycloalkyl (meth)acrylates, wherein said oligomers have a Mn of about 300 g/mole to about 3,000 g/mole; a Mw of about 700 g/mole to about 6,000 g/mole; a Mz of about 900 g/mole to about 10,000 g/mole. The oligomers may have a Yellowness Index, according to ASTM E313 of less than 2. The oligomers of the invention are useful as tackifiers in adhesive compositions, but also are believed to be useful also in general polymer modification as plasticizers, leveling agents, viscosity reducers (i.e., rheology modifiers), and for increasing solids content in solvent-borne applications of all types with little detrimental impact on viscosity. The invention also provides adhesive compositions and laminate articles coated on at least one side with the adhesive compositions of the invention.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: November 1, 2022
    Assignee: Synthomer Adhesive Technologies LLC
    Inventors: Christopher Lee Lester, Sarah Exley Goetz, Timothy Harold Blayney, Gabrielle Rose Ashley, Mark Stanley Pavlin, Douglas Grant Atkins, Zhufang Liu
  • Patent number: 11246893
    Abstract: Methods are described herein for generating beneficial compounds and/or materials such as bacteriocins that include contacting ‘challenger’ microbes with the ‘protagonist’ microorganisms. The challenger microbes do not directly manufacture the beneficial compounds and/or materials and instead stimulate the protagonist microorganisms to produce beneficial compounds and materials. The protagonist and/or challenger microorganisms can be administered to a subject so the beneficial compounds and/or materials can be made in vivo. Compositions and methods of using beneficial compounds and/or materials are also described herein.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: February 15, 2022
    Assignee: ISOThrive Inc.
    Inventors: Lee Madsen, II, Jack Oswald, Sarah Stanley, Yvonne Lorraine Kapila
  • Patent number: 11224646
    Abstract: A vaccine against Mycobacterium tuberculosis (M. tuberculosis) formulated for intranasal administration, comprises a first vaccine component comprising one or more M. tuberculosis, Mycobacterium vaccae (M. vaccae) or Mycobacteroium bovis (M. bovis) antigens, and a second vaccine component comprising a Stimulator of Interferon Genes (STING) activator.
    Type: Grant
    Filed: July 7, 2020
    Date of Patent: January 18, 2022
    Assignee: The Regents of the University of California
    Inventors: Sarah Stanley, Erik Van Dis, Kimberly Sogi, Daniel A. Portnoy, Chris Rae
  • Publication number: 20210269838
    Abstract: Described herein are efficient, low cost methods for making prebiotics that contain maltosyl-isomaltooligosaccharides (MIMOs), as well as compositions made by such methods.
    Type: Application
    Filed: May 19, 2021
    Publication date: September 2, 2021
    Inventors: Lee Madsen, II, Jack Oswald, Sarah Stanley
  • Patent number: 11053527
    Abstract: Described herein are efficient, low cost methods for making prebiotics that contain maltosyl-isomaltooligosaccharides (MIMOs), as well as compositions made by such methods.
    Type: Grant
    Filed: April 11, 2017
    Date of Patent: July 6, 2021
    Assignee: ISOThrive Inc.
    Inventors: Lee Madsen, II, Jack Oswald, Sarah Stanley
  • Publication number: 20210052909
    Abstract: The present invention provides methods and compositions for the remote control of cell function based on the use of a magnetic field to excite paramagnetic nanoparticles targeted to specific cell types. The cell type of interest expresses an ion channel wherein excitation of the paramagnetic nanoparticles results in a physical change that is transduced into a cellular response. Such cellular responses may include, for example, increases in gene expression resulting in production of one or more physiologically active proteins. The expression of such proteins can be used to treat a variety of different inherited or acquired diseases or disorders in a subject.
    Type: Application
    Filed: August 6, 2020
    Publication date: February 25, 2021
    Inventors: SARAH STANLEY, JEFFREY FRIEDMAN, JONATHAN S. DORDICK, JEREMY SAUER
  • Publication number: 20200338182
    Abstract: A vaccine against Mycobacterium tuberculosis (M. tuberculosis) formulated for intranasal administration, comprises a first vaccine component comprising one or more M. tuberculosis, Mycobacterium vaccae (M. vaccae) or Mycobacteroium bovis (M. bovis) antigens, and a second vaccine component comprising a Stimulator of Interferon Genes (STING) activator.
    Type: Application
    Filed: July 7, 2020
    Publication date: October 29, 2020
    Applicant: The Regents of the University of California
    Inventors: Sarah Stanley, Erik Van Dis, Kimberly Sogi, Daniel A. Portnoy, Chris Rae
  • Patent number: 10786570
    Abstract: The present invention provides methods and compositions for the remote control of cell function based on the use of radiofrequency waves to excite nanoparticles targeted to specific cell types. The nanoparticles may be applied to the target cell extracellularly and/or expressed intracellularly. The cell type of interest expresses a temperature sensitive channel wherein excitation of the nanoparticles results in a localized temperature increase that is transduced into a cellular response. Such cellular responses may include, for example, increases in gene expression resulting in production of one or more physiologically active proteins. The expression of such proteins can be used to treat a variety of different inherited or acquired diseases or disorders in a subject. Accordingly, the invention provides a generic approach for treatment of any disease associated with a protein deficiency.
    Type: Grant
    Filed: July 30, 2018
    Date of Patent: September 29, 2020
    Assignee: The Rockefeller University
    Inventors: Jeffrey Friedman, Sarah Stanley
  • Patent number: 10765878
    Abstract: The present invention provides methods and compositions for the remote control of cell function based on the use of a magnetic field to excite paramagnetic nanoparticles targeted to specific cell types. The cell type of interest expresses an ion channel wherein excitation of the paramagnetic nanoparticles results in a physical change that is transduced into a cellular response. Such cellular responses may include, for example, increases in gene expression resulting in production of one or more physiologically active proteins. The expression of such proteins can be used to treat a variety of different inherited or acquired diseases or disorders in a subject.
    Type: Grant
    Filed: March 21, 2017
    Date of Patent: September 8, 2020
    Assignees: THE ROCKEFELLER UNIVERSITY, RENSSELAER POLYTECHNIC INSTITUTE
    Inventors: Sarah Stanley, Jeffrey Friedman, Jonathan S. Dordick, Jeremy Sauer
  • Patent number: 10766872
    Abstract: The invention relates to compounds of Formula I or a pharmaceutically acceptable salt, ester or prodrug thereof:
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: September 8, 2020
    Assignee: The Board Institute, Inc.
    Inventors: Deborah Hung, Sarah Stanley, Tomohiko Kawate, Noriakie Iwase, Motohisa Shimizu
  • Publication number: 20200055905
    Abstract: Methods are described herein for generating beneficial compounds and/or materials such as bacteriocins that include contacting ‘challenger’ microbes with the ‘protagonist’ microorganisms. The challenger microbes do not directly manufacture the beneficial compounds and/or materials and instead stimulate the protagonist microorganisms to produce beneficial compounds and materials. The protagonist and/or challenger microorganisms can be administered to a subject so the beneficial compounds and/or materials can be made in vivo. Compositions and methods of using beneficial compounds and/or materials are also described herein.
    Type: Application
    Filed: November 7, 2017
    Publication date: February 20, 2020
    Inventors: Lee Madsen II, Jack Oswald, Sarah Stanley, Yvonne Lorraine Kapila
  • Publication number: 20190160114
    Abstract: Methods are described herein for identifying and providing prebiotic compositions that are optimized for the health needs of individuals.
    Type: Application
    Filed: July 28, 2017
    Publication date: May 30, 2019
    Inventors: Lee Madsen, II, Jack Oswald, Sarah Stanley
  • Publication number: 20190093139
    Abstract: Described herein are efficient, low cost methods for making prebiotics that contain maltosyl-isomaltooligosaccharides (MIMOs), as well as compositions made by such methods.
    Type: Application
    Filed: April 11, 2017
    Publication date: March 28, 2019
    Inventors: Lee Madsen, II, Jack Oswald, Sarah Stanley
  • Publication number: 20180353605
    Abstract: The present invention provides methods and compositions for the remote control of cell function based on the use of radiofrequency waves to excite nanoparticles targeted to specific cell types. The nanoparticles may be applied to the target cell extracellularly and/or expressed intracellularly. The cell type of interest expresses a temperature sensitive channel wherein excitation of the nanoparticles results in a localized temperature increase that is transduced into a cellular response. Such cellular responses may include, for example, increases in gene expression resulting in production of one or more physiologically active proteins. The expression of such proteins can be used to treat a variety of different inherited or acquired diseases or disorders in a subject. Accordingly, the invention provides a generic approach for treatment of any disease associated with a protein deficiency.
    Type: Application
    Filed: July 30, 2018
    Publication date: December 13, 2018
    Inventors: Jeffrey Friedman, Sarah Stanley
  • Patent number: 10064941
    Abstract: The present invention provides methods and compositions for the remote control of cell function based on the use of radiofrequency waves to excite nanoparticles targeted to specific cell types. The nanoparticles may be applied to the target cell extracellularly and/or expressed intracellularly. The cell type of interest expresses a temperature sensitive channel wherein excitation of the nanoparticles results in a localized temperature increase that is transduced into a cellular response. Such cellular responses may include, for example, increases in gene expression resulting in production of one or more physiologically active proteins. The expression of such proteins can be used to treat a variety of different inherited or acquired diseases or disorders in a subject. Accordingly, the invention provides a generic approach for treatment of any disease associated with a protein deficiency.
    Type: Grant
    Filed: May 31, 2016
    Date of Patent: September 4, 2018
    Assignee: THE ROCKEFELLER UNIVERSITY
    Inventors: Jeffrey Friedman, Sarah Stanley
  • Publication number: 20180200386
    Abstract: The present invention provides methods and compositions for the remote control of cell function based on the use of a magnetic field to excite paramagnetic nanoparticles targeted to specific cell types. The cell type of interest expresses an ion channel wherein excitation of the paramagnetic nanoparticles results in a physical change that is transduced into a cellular response. Such cellular responses may include, for example, increases in gene expression resulting in production of one or more physiologically active proteins. The expression of such proteins can be used to treat a variety of different inherited or acquired diseases or disorders in a subject.
    Type: Application
    Filed: March 21, 2017
    Publication date: July 19, 2018
    Inventors: Sarah Stanley, Jeffrey Friedman, Jonathan S. Dordick, Jeremy Sauer
  • Publication number: 20170327481
    Abstract: The invention relates to compounds of Formula I or a pharmaceutically acceptable salt, ester or prodrug thereof:
    Type: Application
    Filed: May 31, 2017
    Publication date: November 16, 2017
    Inventors: Deborah Hung, Sarah Stanley, Tomohiko Kawate, Noriakie Iwase, Motohisa Shimizu
  • Patent number: 9682064
    Abstract: The invention relates to compounds of Formula I or a pharmaceutically acceptable salt, ester or prodrug thereof:
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: June 20, 2017
    Assignees: The Broad Institute, Inc., Massachusetts General Hospital
    Inventors: Deborah Hung, Sarah Stanley, Tomohiko Kawate, Noriakie Iwase, Motohisa Shimizu
  • Publication number: 20170014378
    Abstract: The invention relates to compounds of Formula I or a pharmaceutically acceptable salt, ester or prodrug thereof:
    Type: Application
    Filed: July 21, 2016
    Publication date: January 19, 2017
    Inventors: Deborah Hung, Sarah Stanley, Tomohiko Kawate, Noriakie Iwase, Motohisa Shimizu
  • Patent number: RE48105
    Abstract: The invention relates to compounds of Formula I or a pharmaceutically acceptable salt, ester or prodrug thereof:
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: July 21, 2020
    Assignees: The Broad Institute, Inc., The General Hospital Corporation
    Inventors: Deborah Hung, Sarah Stanley, Tomohiko Kawate, Noriaki Iwase, Motohisa Shimizu